240

Active sites

A global health challenge

Respiratory tract infections are a significant cause of hospitalisation and illness world-wide, and are the leading cause of deaths from infectious disease globally.

An innovative approach to clinical research

REMAP-CAP uses an innovative trial design that is able to adapt over time to evaluate a number of treatment options simultaneously and efficiently.

An international collaboration

REMAP-CAP is a global network of leading experts, institutions and research networks. With over 250 participating institutions world-wide, REMAP-CAP is a truly global trial.

Pandemic preparedness

Pandemics are impossible to predict, and may spread rapidly throughout the world. The REMAP-CAP trial provides a global research platform that is able to adapt to efficiently evaluate multiple treatment options for patients who are hospitalised due to a global respiratory pandemic.